home / stock / cycc / cycc quote
Last: | $0.3717 |
---|---|
Change Percent: | 2.44% |
Open: | $0.32 |
Close: | $0.3717 |
High: | $0.38 |
Low: | $0.3165 |
Volume: | 674,429 |
Last Trade Date Time: | 02/14/2025 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.3717 | $0.32 | $0.3717 | $0.38 | $0.3165 | 674,429 | 02-14-2025 |
$0.328 | $0.3102 | $0.328 | $0.335 | $0.31 | 383,326 | 02-13-2025 |
$0.3069 | $0.311 | $0.3069 | $0.311 | $0.3014 | 188,068 | 02-12-2025 |
$0.317 | $0.32 | $0.317 | $0.3203 | $0.3049 | 280,397 | 02-11-2025 |
$0.321 | $0.3206 | $0.321 | $0.3345 | $0.3199 | 271,832 | 02-10-2025 |
$0.316 | $0.33 | $0.316 | $0.33 | $0.31 | 248,763 | 02-07-2025 |
$0.3294 | $0.334 | $0.3294 | $0.34 | $0.3129 | 488,833 | 02-06-2025 |
$0.3431 | $0.3515 | $0.3431 | $0.3515 | $0.3339 | 2,082,556 | 02-05-2025 |
$0.3504 | $0.341 | $0.3504 | $0.359 | $0.3366 | 195,256 | 02-04-2025 |
$0.348 | $0.34 | $0.348 | $0.3559 | $0.333 | 158,217 | 02-03-2025 |
$0.333 | $0.3476 | $0.333 | $0.35 | $0.333 | 141,722 | 01-31-2025 |
$0.3584 | $0.3689 | $0.3584 | $0.3739 | $0.3317 | 204,466 | 01-30-2025 |
$0.3562 | $0.379 | $0.3562 | $0.3799 | $0.35 | 94,274 | 01-29-2025 |
$0.354 | $0.3799 | $0.354 | $0.38 | $0.35 | 309,658 | 01-28-2025 |
$0.38 | $0.37 | $0.38 | $0.38 | $0.37 | 375,914 | 01-27-2025 |
$0.371 | $0.35 | $0.371 | $0.4099 | $0.3402 | 1,453,792 | 01-24-2025 |
$0.35 | $0.358 | $0.35 | $0.3599 | $0.3199 | 525,129 | 01-23-2025 |
$0.3532 | $0.3601 | $0.3532 | $0.369 | $0.3501 | 173,221 | 01-22-2025 |
$0.36 | $0.3611 | $0.36 | $0.380399 | $0.3456 | 383,800 | 01-21-2025 |
$0.3559 | $0.365 | $0.3559 | $0.378 | $0.3451 | 252,090 | 01-20-2025 |
News, Short Squeeze, Breakout and More Instantly...
Cyclacel Pharmaceuticals Inc. Company Name:
CYCC Stock Symbol:
NASDAQ Market:
Cyclacel Pharmaceuticals Inc. Website:
BERKELEY HEIGHTS, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company") today announced that the Company entered into a securities purchase agreement (“Agreement”) with investor David Lazar (“Lazar...
BERKELEY HEIGHTS, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative cancer medicines, today announced that it is in the process of exploring and reviewing strategic a...
BERKELEY HEIGHTS, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative cancer medicines, today announced that it closed its previously announced transaction involving th...